Furthermore, Jingbo Sun et al. observed that hyper-expression of CENPF in breast cancer was linked to poor prognostic and bone metastases [18], and Hongjin Chen et al. proposed the involvement of the CENPF-pERK-NEK2 pathway in HCC development [19]. Here, NEK2 is linked to hepatocellular carcinoma.